Information Journal Paper
APA:
Copy. (2020). COVID-19: a potential driver of immune-mediated breast cancer recurrence?. BREAST CANCER RESEARCH, 22(1), 0-0. SID. https://sid.ir/paper/970260/en
Vancouver:
Copy. COVID-19: a potential driver of immune-mediated breast cancer recurrence?. BREAST CANCER RESEARCH[Internet]. 2020;22(1):0-0. Available from: https://sid.ir/paper/970260/en
IEEE:
Copy, “COVID-19: a potential driver of immune-mediated breast cancer recurrence?,” BREAST CANCER RESEARCH, vol. 22, no. 1, pp. 0–0, 2020, [Online]. Available: https://sid.ir/paper/970260/en